Daily News Archive
Daily News Subscription
Study Proves Salix Massively Reduces Bleeding
Race-day application of Salix (trade name of the diuretic furosemide & formerly marketed as Lasix) significantly reduces exercise-induced pulmonary hemorrhage in racehorses, according to a ground-breaking study "that could influence international policy" to be published later today in the Journal of the American Veterinary Medical Association. "The data in the study provides the most reliable information to guide the highly politicised debate over use of furosemide in horses" summed up Kenneth Hinchcliff, the study's co-author & dean of the faculty of veterinary science at the University Of Melbourne. The comprehensive report (co-authored by Paul Morley from Colorado State University in the US & Alan Guthrie from the University Of Pretoria in South Africa) studied thoroughbreds during racing conditions in South Africa in 2007 & found "horses were 3-11 times as likely to have EIPH after placebo administration as they were after administration of furosemide" & "about 2/3 of the horses that had EIPH after administration of the placebo had a reduction in EIPH severity when treated with furosemide". For a full report on the landmark study & its potential implications for future international racing policies relating to the drug (currently given to 92% of North American horses on raceday in an attempt to control bleeding) click on the link in The Great Debate panel on the right-had side of this page.